Sign in:
Email
 Password  save:
  
 Company Reports 
 
   
My Recent Searches
  Help
 
   
 
 
 
  
   
Insider Information:   Akkaraju Srinivas
Relationship:  
City:  
State:  
   
Insider Summary:
  
   
Companies Owned :   19    
Direct Shares   3,961,226    

Indirect Shares

  37,470,445      
Direct Value   $21,956,906    

Indirect Value

  $291,912,501      
Total Shares   41,431,671      
Total Value   $313,869,407      


Seagen Inc
 $9,493,396 Paratek Pharmaceuticals Inc
 $2,635,786 Icagen Inc
 $0 MEI Pharma Inc
 $9,810,878 Aravive Inc
 $1,276 Syros Pharmaceuticals, Inc.
 $15,569 Seagen Inc
 $9,493,396 Paratek Pharmaceuticals Inc
 $2,635,786 Icagen Inc
 $0 MEI Pharma Inc
 $9,810,878 Aravive Inc
 $1,276 Syros Pharmaceuticals, Inc.
 $15,569
 


Historical Performance :
Based on 6 Month Return Percentages
Buys 
Sells 

     Total Filings :

    5   
    3    

     Stock price went up :

    5   
    1    
     Stock price went down :
    0   
    2    
   
     Gain/Loss Ratio :
   5.0   
   5.0   
     Percentage Gain/Loss :
   39.4%
 -84.0%
     
   
Holdings :
     Menu Company Name Ticker Relation Direct Date Direct Shares Indirect Date Indirect Shares Total Value Sold  
            Pharmos Corp PARS Director 0 2006-10-25 2,845,160    Premium*  
            Seagen Inc SGEN Director 2020-05-15 41,503 2008-09-22 600,559    Premium*  
            Paratek Pharmaceuticals Inc PRTK Former 10% Beneficial ... 2011-07-19 1,181,967 0    Premium*  
            World Heart Corp WHRT 10% Owner 2012-08-02 0 2010-01-26 0    Premium*  
            Icagen Inc ICGN 2011-07-28 200,500 0    Premium*  
            Synageva BioPharma Corp GEVA Former Director 0 2012-06-27 1,026,832    Premium*  
            Durata Therapeutics, Inc. DRTX 10% Owner 2012-07-24 0 2012-07-24 3,028,439    Premium*  
            MEI Pharma Inc MEIP 10% Owner 2013-02-19 2,502,775 0    Premium*  
            Zs Pharma, Inc. ZSPH Director 2015-12-17 0 2014-06-23 609,455    Premium*  
            aTyr Pharma Inc LIFE Former 10% Owner, Dire... 2015-05-12 0 2015-05-12 1,866,126    Premium*  
            Aravive Inc ARAV Director 2019-12-02 31,815 2019-12-02 576,066    Premium*  
            Syros Pharmaceuticals, Inc. SYRS Director 2023-12-21 2,666 2023-12-21 1,786,427    Premium*  
            Principia Biopharma Inc PRNB Director 2018-09-18 0 2018-09-18 383,480    Premium*  
            Chinook Therapeutics Inc KDNY Director 2023-08-11 0 2023-08-11 0    Premium*  
            Graphite Bio, Inc. GRPH 10% Owner 2021-06-29 0 2022-04-12 8,497,067    Premium*  
            Scholar Rock Holding Corp SRRK Director, 10% Owner 0 2023-10-16 6,788,609    Premium*  
            Cargo Therapeutics, Inc. CRGX 10% Owner 0 2023-11-14 4,121,689    Premium*  
            Mineralys Therapeutics, Inc. MLYS 2024-02-12 0 2024-02-12 5,074,916    Premium*  
            Vtv Therapeutics Inc. VTVT 2024-02-27 0 2024-02-27 265,620    Premium*  
* Premium Members only  

Records found :    25         Free Registration Required For Full Results.    Limit: 25

Download
  Page 1 of 1
Ticker Company Name Relation   Off-Dir-10% Trans. Date Form Action Price Mkt Value D/I Shares    Holdings   
Rank

 
3m +/-  
Form
VTVT Vtv Therapeutics Inc.   –       •       •   2024-02-27 4 A $11.81 $2,654,085 I/I 224,732 265,620 0 -
VTVT Vtv Therapeutics Inc.   –       •       •   2024-02-23 3 IO $0.00 $0 I/I 0 40,888 -
MLYS Mineralys Therapeutics, I...   –       •       •   2024-02-12 4 A $13.50 $7,499,993 I/I 555,555 5,074,916 0 -
SYRS Syros Pharmaceuticals, In... Director   –       •      –    2023-12-21 4 B $4.42 $3,999,998 I/I 904,977 1,786,427 2.1 %
CRGX Cargo Therapeutics, Inc. 10% Owner   –       –       •   2023-11-14 4 A $0.00 $0 I/I 3,381,323 3,455,023 0 -
CRGX Cargo Therapeutics, Inc. 10% Owner   –       –       •   2023-11-14 4 B $15.00 $9,999,990 I/I 666,666 4,121,689 1.5 -
CRGX Cargo Therapeutics, Inc. 10% Owner   –       –       •   2023-11-09 3 IO $0.00 $0 I/I 0 73,700 -
SRRK Scholar Rock Holding Corp Director   –       •       •   2023-10-16 4 B $6.85 $15,000,000 I/I 2,189,781 6,788,609 2.25 %
SYRS Syros Pharmaceuticals, In... Director   –       •      –    2023-09-16 4 OE $0.00 $0 D/D 2,666 2,666 0 -
KDNY Chinook Therapeutics Inc Director   –       •      –    2023-08-11 4 D $0.00 $0 D/D (3,300) 0 0 -
KDNY Chinook Therapeutics Inc Director   –       •      –    2023-08-11 4 D $0.00 $0 I/I (5,161,888) 0 0 -
KDNY Chinook Therapeutics Inc Director   –       •      –    2023-05-26 4 OE $0.00 $0 D/D 3,300 3,300 0 -
SYRS Syros Pharmaceuticals, In... Director   –       •      –    2022-09-16 4/A A $0.00 $0 I/I 691,489 881,450 0 -
SRRK Scholar Rock Holding Corp Director   –       •      –    2022-07-26 3 IO $0.00 $0 I/I 0 4,598,828 %
KDNY Chinook Therapeutics Inc Director   –       •      –    2022-05-27 4 B $14.00 $7,980,000 I/I 570,000 5,161,888 2.1 %
GRPH Graphite Bio, Inc. 10% Owner   –       –       •   2022-04-12 4 B $4.08 $1,428,000 I/I 350,000 8,459,314 1.5 -
GRPH Graphite Bio, Inc. 10% Owner   –       –       •   2022-04-11 4 B $4.07 $303,068 I/I 74,464 8,109,314 1.5 -
GRPH Graphite Bio, Inc. 10% Owner   –       –       •   2022-01-24 4 B $8.70 $200,100 I/I 23,000 8,034,850 1.5 -
GRPH Graphite Bio, Inc. 10% Owner   –       –       •   2022-01-21 4 B $8.99 $899,000 I/I 100,000 8,011,850 1.5 -
GRPH Graphite Bio, Inc. 10% Owner   –       –       •   2022-01-20 4 B $8.92 $384,497 I/I 43,105 7,911,850 1.5 -
GRPH Graphite Bio, Inc. 10% Owner   –       –       •   2022-01-19 4 B $9.24 $504,181 I/I 54,565 7,868,745 1.5 -
GRPH Graphite Bio, Inc. 10% Owner   –       –       •   2021-12-15 4 B $10.19 $227,533 I/I 22,329 7,814,180 1.5 -
KDNY Chinook Therapeutics Inc Director   –       •      –    2021-11-15 4 B $14.00 $17,010,000 I/I 1,215,000 4,591,888 2.1 %
GRPH Graphite Bio, Inc. 10% Owner   –       –       •   2021-10-15 4 B $12.49 $28,727 I/I 2,300 7,590,166 1.5 -
GRPH Graphite Bio, Inc. 10% Owner   –       –       •   2021-10-14 4 B $12.50 $38,750 I/I 3,100 7,587,866 1.5 -

  25  Records found
  1     
  Page 1 of 1  
 
Free Registration Required For Full Results.    Limit: 25

 
 
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
OE - Options Exercised A - Aquired
  IO - Initital Ownership D - Disposed